Edwards Comments on German Appellate Court Ruling IRVINE, CA -- (Marketwired) -- 11/14/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today said that an appeals court in Germany has suspended the enforcement of an injunction against sales of Medtronic's transcatheter heart valves in Germany, pending the posting of a EUR 5 million bond by Medtronic. This action comes after the European Patent Office (EPO) issued a non-binding preliminary opinion in October indicating concerns about the validity of the Edwards Spenser patent. About Edwards Lifesciences Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at www.edwards.com. Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. Media Contact: Sarah Huoh 949-250-5070 Investor Contact: David K. Erickson 949-250-6826
Edwards Comments on German Appellate Court Ruling
Press spacebar to pause and continue. Press esc to stop.